Nonsyndromic congenital nail disorder 6
disease diseaseOn this page
Also known as absent nails and dystrophic nailsnail disorder, nonsyndromic congenital, 6NDNC6nonsyndromic congenital nail disorder type 6onychodystrophy-anonychia
Summary
Nonsyndromic congenital nail disorder 6 (MONDO:0007135) is a disease. A subtype of isolated congenital anonychia — broader associated-gene and molecular evidence is on the parent page (see Disease family below).
Clinical features
No curated clinical features (Orphanet) for this disease.
Identifiers
Disease identifiers
| Field | Value |
|---|---|
| Canonical name | nonsyndromic congenital nail disorder 6 |
| Mondo ID | MONDO:0007135 |
| OMIM | 107000 |
| DOID | DOID:0080084 |
| UMLS | C3275544 |
| MedGen | 477175 |
| GARD | 0015040 |
| Is cancer (heuristic) | no |
Also known as: absent nails and dystrophic nails · nail disorder, nonsyndromic congenital, 6 · NDNC6 · nonsyndromic congenital nail disorder type 6 · onychodystrophy-anonychia
Disease family
Classification path: disease › human disease › disease by body system or component › integumentary system disorder › nail disorder › inherited isolated nail anomaly › isolated congenital anonychia › nonsyndromic congenital nail disorder 6
Related subtypes (2): nonsyndromic congenital nail disorder 4, anonychia-onychodystrophy syndrome
Genetics & variants
GWAS landscape
No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.
Variant details and genetic-evidence tiers
No tiered GWAS variants or ClinVar records for this disease.
Genes & proteins
No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).
Function
No pathway enrichment — requires an associated-gene cohort.
Therapeutics
No druggable-target or therapeutic data for this disease’s cohort.
Clinical trials & evidence
Clinical trials
Clinical trials: 0.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.